The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.
Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
87 | 87 | 83 | 43 |
Growth
|
63 | 19 | 9 | 11 |
Safety
|
52 | 72 | 51 | 1 |
Sentiment
|
10 | 10 | 12 | 20 |
|
34 | 34 | 15 | 1 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Analyst Opinions
|
50 | 50 | 50 | 63 |
Opinions Change
|
50 | 50 | 50 | 50 |
Pro Holdings
|
n/a | 8 | 10 | 20 |
Market Pulse
|
9 | 9 | 9 | 29 |
Sentiment
|
10 | 10 | 12 | 20 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
87 | 87 | 83 | 43 |
Growth
|
63 | 19 | 9 | 11 |
|
52 | 72 | 51 | 1 |
Combined
|
43 | 80 | 44 | 6 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Price vs. Sales (P/S)
|
52 | 52 | 52 | 52 |
Price vs. Earnings (P/E)
|
100 | 100 | 95 | 75 |
Price vs. Book (P/B)
|
97 | 100 | 87 | 1 |
Dividend Yield
|
1 | 1 | 1 | 1 |
Value
|
87 | 87 | 83 | 43 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Revenue Growth
|
33 | 33 | 55 | 51 |
Profit Growth
|
87 | 85 | 50 | 23 |
Capital Growth
|
13 | 12 | 9 | 19 |
Stock Returns
|
100 | 1 | 19 | 33 |
Growth
|
63 | 19 | 9 | 11 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Leverage
|
12 | 13 | 10 | 4 |
Refinancing
|
99 | 100 | 87 | 1 |
Liquidity
|
23 | 36 | 45 | 50 |
|
52 | 72 | 51 | 1 |
Discover high‑ranked alternatives to Minerva Surgical and broaden your portfolio horizons.
The Obermatt Advantage
Choose the Obermatt subscription that best fits your needs.